CD103+ Conventional Dendritic Cells Are Critical for TLR7/9-Dependent Host Defense against Histoplasma capsulatum, an Endemic Fungal Pathogen of Humans

PLoS Pathogens

Volumn 12, Issue 7, 2016, Pages

  Van Prooyen, Nancy ^a   Henderson, C Allen ^a   Hocking Murray, Davina ^a   Sil, Anita ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; GAMMA INTERFERON; INTERFERON; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; ALPHA E INTEGRINS; ALPHA INTEGRIN; CYTOKINE; LEUKOCYTE ANTIGEN;

ADAPTIVE IMMUNITY; AJELLOMYCES CAPSULATUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL HYBRIDIZATION; CELL PROLIFERATION; CELL VIABILITY; CYTOKINE PRODUCTION; CYTOTOXICITY ASSAY; FEMALE; FLOW CYTOMETRY; FUNGUS GROWTH; GENE EXPRESSION; GENE MUTATION; HOST RESISTANCE; IMMUNE RESPONSE; INNATE IMMUNITY; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COCULTURE; DENDRITIC CELL; DISEASE MODEL; DNA MICROARRAY; HISTOPLASMA; HISTOPLASMOSIS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MACROPHAGE; PARASITOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; HISTOPLASMA; HISTOPLASMOSIS; HUMANS; INTEGRIN ALPHA CHAINS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84982893723     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005749     Document Type: Article

References (54)

1. Carrero JA, Confounding roles for type I interferons during bacterial and viral pathogenesis. Int Immunol. 2013;25(12):663–9. Epub 2013/10/26. doi: 10.1093/intimm/dxt050 dxt050 [pii]. 24158954; PubMed Central PMCID: PMC3839063.
2. Honda K, Takaoka A, Taniguchi T, Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity. 2006;25(3):349–60. Epub 2006/09/19. S1074-7613(06)00394-3 [pii] doi: 10.1016/j.immuni.2006.08.00916979567.
3. Unterholzner L, The interferon response to intracellular DNA: why so many receptors?Immunobiology. 2013;218(11):1312–21. Epub 2013/08/22. doi: 10.1016/j.imbio.2013.07.007 S0171-2985(13)00142-3 [pii]. 23962476.
4. Ivashkiv LB, Donlin LT, Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36–49. Epub 2013/12/24. doi: 10.1038/nri3581 nri3581 [pii]. 24362405; PubMed Central PMCID: PMC4084561.
5. Bourgeois C, Majer O, Frohner IE, Lesiak-Markowicz I, Hildering KS, Glaser W, et al. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-beta signaling. J Immunol. 2011;186(5):3104–12. Epub 2011/02/02. doi: 10.4049/jimmunol.1002599 jimmunol.1002599 [pii]. 21282509.
6. Carvalho A, De Luca A, Bozza S, Cunha C, D'Angelo C, Moretti S, et al. TLR3 essentially promotes protective class I-restricted memory CD8(+) T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood. 2012;119(4):967–77. Epub 2011/12/08. doi: 10.1182/blood-2011-06-362582 blood-2011-06-362582 [pii]. 22147891.
7. Kasperkovitz PV, Cardenas ML, Vyas JM, TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking. J Immunol. 2010;185(12):7614–22. Epub 2010/11/10. doi: 10.4049/jimmunol.1002760 jimmunol.1002760 [pii]. 21059889; PubMed Central PMCID: PMC3600358.
8. Ramaprakash H, Hogaboam CM, Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner. Int Arch Allergy Immunol. 2010;152(2):98–112. Epub 2009/12/18. doi: 10.1159/000265531 000265531 [pii]. 20016192; PubMed Central PMCID: PMC2883833.
9. Biondo C, Malara A, Costa A, Signorino G, Cardile F, Midiri A, et al. Recognition of fungal RNA by TLR7 has a nonredundant role in host defense against experimental candidiasis. Eur J Immunol. 2012;42(10):2632–43. Epub 2012/07/11. doi: 10.1002/eji.20124253222777843.
10. Wu J, Chen ZJ, Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol. 2014;32:461–88. Epub 2014/03/25. doi: 10.1146/annurev-immunol-032713-12015624655297.
11. Steinman RM, Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J Med. 2001;68(3):160–6. Epub 2001/05/25. 11373688.
12. Schraml BU, Reis e Sousa C, Defining dendritic cells. Curr Opin Immunol. 2015;32:13–20. Epub 2015/01/02. doi: 10.1016/j.coi.2014.11.001 S0952-7915(14)00148-4 [pii]. 25553392.
13. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C, et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol. 2001;2(12):1144–50. Epub 2001/11/20. doi: 10.1038/ni736 ni736 [pii]. 11713464.
14. Gildea LA, Morris RE, Newman SL, Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J Immunol. 2001;166(2):1049–56. Epub 2001/01/06. 11145684.
15. Baughman RP, Kim CK, Vinegar A, Hendricks DE, Schmidt DJ, Bullock WE, The pathogenesis of experimental pulmonary histoplasmosis. Correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. The American review of respiratory disease. 1986;134(4):771–6. Epub 1986/10/01. 3767131.
16. Deepe GS, Jr.Gibbons RS, Smulian AG, Histoplasma capsulatum manifests preferential invasion of phagocytic subpopulations in murine lungs. Journal of leukocyte biology. 2008;84(3):669–78. Epub 2008/06/26. doi: 10.1189/jlb.030815418577715; PubMed Central PMCID: PMC2516902.
17. Woods JP, Knocking on the right door and making a comfortable home: Histoplasma capsulatum intracellular pathogenesis. Curr Opin Microbiol. 2003;6(4):327–31. Epub 2003/08/28. S1369527403000808 [pii]. 12941399.
18. Nosanchuk JD, Gacser A, Histoplasma capsulatum at the host-pathogen interface. Microbes Infect. 2008;10(9):973–7. Epub 2008/08/02. doi: 10.1016/j.micinf.2008.07.011 S1286-4579(08)00188-3 [pii]. 18672088; PubMed Central PMCID: PMC2586805.
19. Inglis DO, Berkes CA, Hocking Murray DR, Sil A, Conidia but not yeast cells of the fungal pathogen Histoplasma capsulatum trigger a type I interferon innate immune response in murine macrophages. Infection and immunity. 2010;78(9):3871–82. Epub 2010/07/08. IAI.00204-10 [pii] doi: 10.1128/IAI.00204-1020605974; PubMed Central PMCID: PMC2937464.
20. Gildea LA, Ciraolo GM, Morris RE, Newman SL, Human dendritic cell activity against Histoplasma capsulatum is mediated via phagolysosomal fusion. Infect Immun. 2005;73(10):6803–11. Epub 2005/09/24. 73/10/6803 [pii] doi: 10.1128/IAI.73.10.6803–6811.200516177358; PubMed Central PMCID: PMC1230966.
21. Porta A, Maresca B, Host response and Histoplasma capsulatum/macrophage molecular interactions. Med Mycol. 2000;38(6):399–406. Epub 2001/02/24. 11204877.
22. Helft J, Bottcher J, Chakravarty P, Zelenay S, Huotari J, Schraml BU, et al. GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. Immunity. 2015;42(6):1197–211. Epub 2015/06/18. doi: 10.1016/j.immuni.2015.05.018 S1074-7613(15)00216-2 [pii]. 26084029.
23. Isaac DT, Berkes CA, English BC, Hocking Murray D, Lee YN, Coady A, et al. Macrophage cell death and transcriptional response are actively triggered by the fungal virulence factor Cbp1 during H. capsulatum infection. Mol Microbiol. 2015;98(5):910–29. Epub 2015/08/20. doi: 10.1111/mmi.1316826288377.
24. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, et al. CD14 is required for MyD88-independent LPS signaling. Nat Immunol. 2005;6(6):565–70. Epub 2005/05/17. ni1207 [pii] doi: 10.1038/ni120715895089.
25. McWhirter SM, Barbalat R, Monroe KM, Fontana MF, Hyodo M, Joncker NT, et al. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP. J Exp Med. 2009;206(9):1899–911. doi: 10.1084/jem.2008287419652017; PubMed Central PMCID: PMCPMC2737161.
26. Malmgaard L, Induction and regulation of IFNs during viral infections. J Interferon Cytokine Res. 2004;24(8):439–54. Epub 2004/08/24. doi: 10.1089/107999004168966515320958.
27. Savva A, Roger T, Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol. 2013;4:387. Epub 2013/12/05. doi: 10.3389/fimmu.2013.0038724302927; PubMed Central PMCID: PMC3831162.
28. Khoo JJ, Forster S, Mansell A, Toll-like receptors as interferon-regulated genes and their role in disease. J Interferon Cytokine Res. 2011;31(1):13–25. Epub 2011/01/05. doi: 10.1089/jir.2010.009521198355.
29. Coady A, Sil A, MyD88-Dependent Signaling Drives Host Survival and Early Cytokine Production during Histoplasma capsulatum Infection. Infect Immun. 2015;83(4):1265–75. Epub 2015/01/15. doi: 10.1128/IAI.02619-14 IAI.02619-14 [pii]. 25583527; PubMed Central PMCID: PMC4363404.
30. Scheu S, Dresing P, Locksley RM, Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo. Proc Natl Acad Sci U S A. 2008;105(51):20416–21. Epub 2008/12/18. doi: 10.1073/pnas.0808537105 0808537105 [pii]. 19088190; PubMed Central PMCID: PMC2629269.
31. Alsharifi M, Mullbacher A, Regner M, Interferon type I responses in primary and secondary infections. Immunol Cell Biol. 2008;86(3):239–45. Epub 2008/01/09. doi: 10.1038/sj.icb.7100159 7100159 [pii]. 18180794.
32. Edelson BT, Kc W, Juang R, Kohyama M, Benoit LA, Klekotka PA, et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J Exp Med. 2010;207(4):823–36. Epub 2010/03/31. doi: 10.1084/jem.20091627 jem.20091627 [pii]. 20351058; PubMed Central PMCID: PMC2856032.
33. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162(4):2347–52. Epub 1999/02/11. 9973514.
34. Wu-Hsieh BA, Howard DH, Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect Immun. 1987;55(4):1014–6. Epub 1987/04/01. 3104206; PubMed Central PMCID: PMC260455.
35. Allendoerfer R, Deepe GS, JrIntrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice. Infect Immun. 1997;65(7):2564–9. Epub 1997/07/01. 9199420; PubMed Central PMCID: PMC175362.
36. Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE, Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis. 2006;42(6):822–5. Epub 2006/02/16. CID38038 [pii] doi: 10.1086/50040516477560.
37. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC, Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13. Epub 2012/12/21. doi: 10.1126/scitranslmed.3004404 4/165/165rv13 [pii]. 23253612.
38. Watts C, West MA, Zaru R, TLR signalling regulated antigen presentation in dendritic cells. Curr Opin Immunol. 2010;22(1):124–30. Epub 2010/01/20. doi: 10.1016/j.coi.2009.12.005 S0952-7915(09)00228-3 [pii]. 20083398.
39. Barbalat R, Ewald SE, Mouchess ML, Barton GM, Nucleic acid recognition by the innate immune system. Annu Rev Immunol. 2011;29:185–214. Epub 2011/01/12. doi: 10.1146/annurev-immunol-031210-10134021219183.
40. Eissenberg LG, Goldman WE, Schlesinger PH, Histoplasma capsulatum modulates the acidification of phagolysosomes. J Exp Med. 1993;177(6):1605–11. Epub 1993/06/01. 8496679; PubMed Central PMCID: PMC2191039.
41. Isaac DT, Coady A, Van Prooyen N, Sil A, The 3-hydroxy-methylglutaryl coenzyme A lyase HCL1 is required for macrophage colonization by human fungal pathogen Histoplasma capsulatum. Infect Immun. 2013;81(2):411–20. Epub 2012/11/28. doi: 10.1128/IAI.00833-12 IAI.00833-12 [pii]. 23184522; PubMed Central PMCID: PMC3553812.
42. van de Veerdonk FL, Netea MG, Jansen TJ, Jacobs L, Verschueren I, van der Meer JW, et al. Redundant role of TLR9 for anti-Candida host defense. Immunobiology. 2008;213(8):613–20. Epub 2008/10/28. doi: 10.1016/j.imbio.2008.05.002 S0171-2985(08)00063-6 [pii]. 18950591.
43. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7(3):240–58. Epub 2015/02/01. doi: 10.15252/emmm.201404556 emmm.201404556 [pii]. 25637383; PubMed Central PMCID: PMC4364943.
44. Wang JP, Lee CK, Akalin A, Finberg RW, Levitz SM, Contributions of the MyD88-dependent receptors IL-18R, IL-1R, and TLR9 to host defenses following pulmonary challenge with Cryptococcus neoformans. PLoS One. 2011;6(10):e26232. Epub 2011/11/01. doi: 10.1371/journal.pone.0026232 PONE-D-11-13511 [pii]. 22039448; PubMed Central PMCID: PMC3198470.
45. Zhang Y, Wang F, Bhan U, Huffnagle GB, Toews GB, Standiford TJ, et al. TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs. Am J Pathol. 2010;177(2):754–65. Epub 2010/06/29. doi: 10.2353/ajpath.2010.091104 S0002-9440(10)60132-0 [pii]. 20581055; PubMed Central PMCID: PMC2913381.
46. Menino JF, Saraiva M, Gomes-Alves AG, Lobo-Silva D, Sturme M, Gomes-Rezende J, et al. TLR9 activation dampens the early inflammatory response to Paracoccidioides brasiliensis, impacting host survival. PLoS Negl Trop Dis. 2013;7(7):e2317. Epub 2013/08/13. doi: 10.1371/journal.pntd.0002317 PNTD-D-13-00349 [pii]. 23936560; PubMed Central PMCID: PMC3723571.
47. Kim TH, Lee HK, Differential roles of lung dendritic cell subsets against respiratory virus infection. Immune Netw. 2014;14(3):128–37. Epub 2014/07/08. doi: 10.4110/in.2014.14.3.12824999309; PubMed Central PMCID: PMC4079819.
48. Zelante T, Wong AY, Ping TJ, Chen J, Sumatoh HR, Vigano E, et al. CD103(+) Dendritic Cells Control Th17 Cell Function in the Lung. Cell Rep. 2015;12(11):1789–801. Epub 2015/09/15. doi: 10.1016/j.celrep.2015.08.030 S2211-1247(15)00915-8 [pii]. 26365185.
49. Kim CC, Nelson CS, Wilson EB, Hou B, DeFranco AL, DeRisi JL, Splenic red pulp macrophages produce type I interferons as early sentinels of malaria infection but are dispensable for control. PLoS One. 2012;7(10):e48126. Epub 2012/11/13. doi: 10.1371/journal.pone.0048126 PONE-D-12-01530 [pii]. 23144737; PubMed Central PMCID: PMC3483282.
50. Dresing P, Borkens S, Kocur M, Kropp S, Scheu S, A fluorescence reporter model defines "Tip-DCs" as the cellular source of interferon beta in murine listeriosis. PLoS One. 2010;5(12):e15567. Epub 2010/12/24. doi: 10.1371/journal.pone.001556721179567; PubMed Central PMCID: PMC3002951.
51. Trofa D, Nosanchuk JD, Histoplasmosis of the Central Nervous System. Journal of Neuroparasitology. 2012;3:1–7.
52. Parihar A, Tomar V, Ojha BK, Husain N, Gupta RK, Magnetic resonance imaging findings in a patient with isolated histoplasma brain abscess. Arch Neurol. 2011;68(4):534–5. Epub 2011/04/13. doi: 10.1001/archneurol.2011.59 68/4/534 [pii]. 21482935.
53. Stetson DB, Medzhitov R, Type I interferons in host defense. Immunity. 2006;25(3):373–81. Epub 2006/09/19. S1074-7613(06)00392-X [pii] doi: 10.1016/j.immuni.2006.08.00716979569.
54. Worsham PL, Goldman WE, Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol. 1988;26(3):137–43. Epub 1988/06/01. 3171821.